-+ 0.00%
-+ 0.00%
-+ 0.00%

ELICIO THERAPEUTICS REPORTS ROBUST T CELL RESPONSES ACROSS DIVERSE HLA BACKGROUNDS IN ONGOING PHASE 2 AMPLIFY-7P TRIAL

Reuters·10/27/2025 12:00:04

Please log in to view news